Expression Therapeutics, Inc., has presented the results of a Phase 1 clinical trial for its novel lentiviral vector-based gene therapy ? ET3 ? for hemophilia A at the Annual Meeting of the American ...

Purgatory is not a second-chance for damned souls to repent. Instead it is a state of cleansing and purification for souls destined for heaven. Also Purgatory is not a means to earn our way to ...

Even indoor purification has limitations for those living in unsealed homes, where outdoor pollutants infiltrate easily. While outdoor air pollution dominates discussions, indoor sources also ...

To develop the next generation of in vivo T cell therapy, Novartis will leverage Vyriad's active targeting lentiviral vector platform to discover and develop new in vivo CAR-T cell therapy candidates.